10X Genomics
10x Genomics, Inc. is an American company incorporated in 2012 that develops and manufactures integrated systems for whole genome sequencing, exome sequencing and single cell transcriptomics. Its headquarters are located in Pleasanton, California.
10X Genomics Company Profile
President & CEO: Serge Saxonov
CEO photo:
Website: http://10xgenomics.com
Headquarters: Pleasanton, CA
10x Genomics employees: 101-250
Funding: $113M USD
Founded: 2012
Founders: Serge Saxonov, Ben Hindson
10x Genomics News
'NicheCompass' AI Model Analyzes Cellular Communication in Cancer, Development
Using an AI neural network approach, researchers came up with the NicheCompass method to profile communication niches based on large spatial omics and expression datasets.
Parse Biosciences, 10x Genomics Reach Agreement on ATAC-seq Patents
The agreement comes after the US Patent Trial and Appeal Board recently invalidated three other patents that 10x had asserted against Parse.
Bruker, Illumina, 10x Genomics, Singular Genomics, Scale Bio, and Parse Bio touted better multiplexing, throughput, and multiomics capabilities for their technologies.
Between 20 percent and 25 percent of 10x Genomics' revenues are tied to NIH-funded projects, and grant money heading 10x's way was already expected to be down.
Top Five Articles on GenomeWeb Last Week: Illumina, Fore Genomics, Inocras, Roche, More
Last week, GenomeWeb's readers were most interested in Illumina potentially facing sanctions after being placed on China's "unreliable entities" list.